Szpital Specjalistyczny W Zabrzu Sp. z o.o.
- Address
- Ul. Marii Curie-Sklodowskiej 10, 41-800 Zabrze, Poland
Szpital Specjalistyczny W Zabrzu - Cardiovascular Research Center
Szpital Specjalistyczny W Zabrzu is a specialized hospital conducting advanced clinical research in cardiovascular medicine, with particular emphasis on heart failure and post-myocardial infarction care. The center focuses on innovative therapeutic approaches aimed at improving cardiovascular outcomes and quality of life in patients with complex cardiac conditions.
- Iron deficiency management in patients following acute myocardial infarction
- Heart failure with reduced ejection fraction and pulmonary hypertension treatment
- Advanced hemodynamic monitoring using right heart catheterization
- Novel pharmacological interventions including sacubitril/valsartan and intravenous iron therapy
The research center demonstrates expertise in evaluating long-term cardiovascular outcomes, including mortality reduction, prevention of heart failure events, and improvement in quality of life metrics. Their studies incorporate sophisticated methodologies such as hemodynamic assessments of pulmonary artery pressure and pulmonary vascular resistance, alongside comprehensive clinical endpoints and patient-reported outcomes using standardized instruments like the EQ-5D quality of life questionnaire.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Agencja Badań Medycznych1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Agencja Badań Medycznych2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Szpital Specjalistyczny W Zabrzu Sp. z o.o.
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Intravenous Ferric Carboxymaltose on Mortality and Cardiovascular Morbidity in Iron-Deficient Patients Post-Myocardial Infarction | Agencja Badań Medycznych, Wroclaw Medical University | Phase III | Recruiting | Sep 2022 | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Enalapril Maleate | 1 | Unknown | 2022-12-12 | 2022-12-12 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.